Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia (Englisch)
- Neue Suche nach: Samara, Aladin
- Neue Suche nach: Anbar, Michael
- Neue Suche nach: Shapira, Saar
- Neue Suche nach: Zemlyansky, Anna
- Neue Suche nach: Zozovsky, Alla
- Neue Suche nach: Raanani, Pia
- Neue Suche nach: Granot, Galit
- Neue Suche nach: Rozovski, Uri
- Neue Suche nach: Samara, Aladin
- Neue Suche nach: Anbar, Michael
- Neue Suche nach: Shapira, Saar
- Neue Suche nach: Zemlyansky, Anna
- Neue Suche nach: Zozovsky, Alla
- Neue Suche nach: Raanani, Pia
- Neue Suche nach: Granot, Galit
- Neue Suche nach: Rozovski, Uri
In:
Hematological Oncology
;
41
, 3
;
487-498
;
2023
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia
-
Beteiligte:Samara, Aladin ( Autor:in ) / Anbar, Michael ( Autor:in ) / Shapira, Saar ( Autor:in ) / Zemlyansky, Anna ( Autor:in ) / Zozovsky, Alla ( Autor:in ) / Raanani, Pia ( Autor:in ) / Granot, Galit ( Autor:in ) / Rozovski, Uri ( Autor:in )
-
Erschienen in:Hematological Oncology ; 41, 3 ; 487-498
-
Verlag:
-
Erscheinungsdatum:01.08.2023
-
Format / Umfang:12 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 41, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 291
-
Issue Information| 2023
- 293
-
Richter transformation in Chronic Lymphocytic LeukemiaInnocenti, Idanna / Benintende, Giulia / Tomasso, Annamaria / Fresa, Alberto / Autore, Francesco / Larocca, Luigi Maria / Laurenti, Luca et al. | 2023
- 301
-
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancyCao, Han‐Yu / Li, Ling / Xue, Sheng‐Li / Dai, Hai‐Ping et al. | 2023
- 310
-
TAFRO syndrome: A disease that known is half curedChen, Tingting / Feng, Chun / Zhang, Xinyou / Zhou, Jihao et al. | 2023
- 323
-
The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myelomaEseonu, Kelechi C. / Panchmatia, Jaykar R. / Streetly, Matthew J. / Grauer, Jonathan N. / Fakouri, Bahram et al. | 2023
- 335
-
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patientsDerenzini, Enrico / Gueli, Angela / Risso, Alessandra / Bruna, Riccardo / Gottardi, Daniela / Cignetti, Alessandro / Pileri, Stefano / Avvedimento, Enrico V. / Tarella, Corrado et al. | 2023
- 343
-
Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective studyAssanto, Giovanni Manfredi / Di Rocco, Alice / Malfona, Francesco / Capriata, Marcello / Del Giudice, Ilaria / Petrucci, Luigi / Girardi, Paola / D’Elia, Gianna Maria / Martelli, Maurizio / Gentile, Giuseppe et al. | 2023
- 354
-
Risk of a second cancer and infection in patients with indolent B‐cell lymphoma exposed to first‐line bendamustine plus rituximab: A retrospective analysis of an administrative claims databaseDote, Satoshi / Inose, Ryo / Goto, Ryota / Kobayashi, Yuka / Muraki, Yuichi et al. | 2023
- 363
-
Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective studyMattiello, Veronica / Barone, Angelica / Giannarelli, Diana / Noto, Alessandro / Cecchi, Nicola / Rampi, Nicolò / Cassin, Ramona / Reda, Gianluigi et al. | 2023
- 371
-
Malnutrition diagnosed by GLIM criteria better predicts long‐term outcomes for patients with non‐Hodgkin's lymphoma: A prospective multicenter cohort studyZou, Yuanlin / Xu, Hongxia / Lyu, Quanjun / Weng, Min / Cui, Jiuwei / Shi, Hanping / Song, Chunhua et al. | 2023
- 380
-
Prognostic value of prognostic nutritional index on extranodal natural killer/T‐cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working GroupShen, Ziyuan / Zhang, Shuo / Chen, Xicheng / Zhang, Qing / Jiao, Yaxue / Shi, Yuye / Zhang, Hao / Ye, Jingjing / Wang, Ling / Zhu, Taigang et al. | 2023
- 389
-
Lenalidomide treatment for recurrent adult T‐cell leukemia/lymphoma after allogeneic hematopoietic cell transplantationTanaka, Takashi / Inamoto, Yoshihiro / Ito, Ayumu / Watanabe, Mizuki / Takeda, Wataru / Aoki, Jun / Kim, Sung‐Won / Fukuda, Takahiro et al. | 2023
- 396
-
Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective studyTian, Jing / Hao, Miaowang / Liu, Qiang / Xiao, Fang / Li, Yuanchun / Qi, Meiying / Gao, Jing / Liu, Li / Yin, Dandan et al. | 2023
- 407
-
Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general populationNúñez‐García, Beatriz / Clemente, Mariola Blanco / Sánchez, Juan Cristóbal / Royuela, Ana / Ibargüen, Blanca Cantos Sánchez de / Méndez, Miriam / López‐Ibor, Jorge V. / Martínez, Marta / Traseira, Cristina / Garitaonaindia, Yago et al. | 2023
- 415
-
Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trialBiggi, Alberto / Chauvie, Stephane / Fallanca, Federico / Guerra, Luca / Bergesio, Fabrizio / Menga, Massimo / Bianchi, Andrea / Gregianin, Michele / Chiaravalloti, Agostino / Schillaci, Orazio et al. | 2023
- 424
-
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patientsAsano, Arisa / Ri, Masaki / Masaki, Ayako / Maeda, Yasuhiro / Tachita, Takuto / Hirade, Kentaro / Marumo, Yoshiaki / Nakashima, Takahiro / Hagiwara, Shinya / Kinoshita, Shiori et al. | 2023
- 434
-
Diagnostic relevance of 2‐[18F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significanceRudolphi‐Solero, Teodoro / Triviño‐Ibáñez, Eva María / González‐Jiménez, Antonio Daniel / Ramos‐Font, Carlos / Ríos‐Tamayo, Rafael / Rebollo‐Aguirre, Angel Custodio / Sánchez‐Sánchez, Rocío et al. | 2023
- 442
-
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studySunami, Kazutaka / Fuchida, Shin‐ichi / Suzuki, Kenshi / Ri, Masaki / Matsumoto, Morio / Shimazaki, Chihiro / Asaoku, Hideki / Shibayama, Hirohiko / Ishizawa, Kenichi / Takamatsu, Hiroyuki et al. | 2023
- 453
-
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myelomaKauer, Joseph / Sester, Lilli Sophie / Kriegsmann, Katharina / Weinhold, Niels / Ober, Michael / Müller‐Tidow, Carsten / Goldschmidt, Hartmut / Raab, Marc‐Steffen / Sauer, Sandra et al. | 2023
- 463
-
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromesLee, Wan‐Hsuan / Lin, Chien‐Chin / Wang, Yu‐Hung / Yao, Chi‐Yuan / Kuo, Yuan‐Yeh / Tseng, Mei‐Hsuan / Peng, Yen‐Ling / Hsu, Cheng‐An / Sun, Hsun‐I / Chuang, Yi‐Kuang et al. | 2023
- 474
-
Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin‐dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosisWang, Fuping / Zhang, Haotian / He, Binghong / Liu, Zihan / Wu, Xinxin / Liu, Yuankai / Xu, Xin / Gou, Xiaoxue / Wang, Haitao / Yang, Qiong et al. | 2023
- 487
-
Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemiaSamara, Aladin / Anbar, Michael / Shapira, Saar / Zemlyansky, Anna / Zozovsky, Alla / Raanani, Pia / Granot, Galit / Rozovski, Uri et al. | 2023
- 499
-
Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approachCheng, Po‐Liang / Hsiao, Tzu‐Hung / Chen, Chung‐Hsing / Hung, Miao‐Neng / Jhan, Pei‐Pei / Lee, Li‐Wen / Wu, Ting‐Shuan / Tsai, Jia‐Rung / Teng, Chieh‐Lin Jerry et al. | 2023
- 510
-
Knockdown of let‐7b in leukemia associated macrophages inhibit acute myeloid leukemia progressionTian, Chen / Li, Yueyang / Si, Junqi / Kang, Junnan / Chen, Zehui / Nuermaimaiti, Rexidan / Wang, Yafei / Yu, Yong / Zhao, Zhigang / Wang, Xiaofang et al. | 2023
- 520
-
Capitalizing on paradoxical activation of the mitogen‐activated protein kinase pathway for treatment of Imatinib‐resistant mast cell leukemiaWilhelm, Thomas / Toledo, Marcelo A. S. / Simons, Ilka / Stuth, Christian / Mohta, Vrinda / Mülfarth, Ronja / Nitsche, Marcus / Maschke‐Neuß, Karin / Schmitz, Susanne / Kaiser, Anne et al. | 2023
- 535
-
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working groupYanagisawa, Ryu / Tamaki, Masaharu / Tanoshima, Reo / Misaki, Yukiko / Uchida, Naoyuki / Koi, Satoshi / Tanaka, Takashi / Ozawa, Yukiyasu / Matsuo, Yayoi / Tanaka, Masatsugu et al. | 2023
- 546
-
15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center studyMei, Chen / Ye, Li / Ren, Yanling / Zhou, Xinping / Ma, Liya / Xu, Gaixiang / Xu, Weilai / Lu, Chenxi / Yang, Haiyang / Luo, Yingwan et al. | 2023
- 555
-
COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationMasina, Lorenzo / Bianchetti, Nicola / Passi, Angela / Bottelli, Chiara / Bagnasco, Samuele / Spolzino, Angelica / Oberti, Margherita / Chiarini, Marco / Belotti, Angelo / Voltolini, Simone et al. | 2023
- 559
-
COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patientsDel Poeta, Giovanni / Laureana, Roberta / Bomben, Riccardo / Rossi, Francesca Maria / Pozzo, Federico / Zaina, Eva / Cattarossi, Ilaria / Varaschin, Paola / Nanni, Paola / Boschian Boschin, Romina et al. | 2023
- 563
-
Safety and efficacy of SARS‐Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR‐T cell infusionMetafuni, Elisabetta / Cingolani, Antonella / Fantoni, Massimo / Chiusolo, Patrizia / Giammarco, Sabrina / Sorà, Federica / Galli, Eugenio / Hohaus, Stefan / D’Alò, Francesco / Bellesi, Silvia et al. | 2023
- 567
-
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemiaMoia, Riccardo / Dondolin, Riccardo / De Propris, Maria Stefania / Talotta, Donatella / Mouhssine, Samir / Perutelli, Francesca / Reda, Gianluigi / Mattiello, Veronica / Rigolin, Gian Matteo / Motta, Marina et al. | 2023
- 571
-
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomasAutore, Francesco / Fresa, Alberto / Innocenti, Idanna / Principe, Maria Ilaria Del / Maglione, Raffaele / Stefanizzi, Caterina / Pelliccia, Sabrina / Romeo, Azzurra / Cimino, Giuseppe / Papa, Elena et al. | 2023
- 574
-
Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM studyVarettoni, Marzia / Zibellini, Silvia / Merli, Michele / Drandi, Daniela / Jiménez, Cristina / Furlan, Daniela / Ferretti, Virginia Valeria / Fabbri, Nicole / Dogliotti, Irene / Varraso, Chiara et al. | 2023
- 578
-
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myelomaXu, Ning / Yu, Erin / Ng, Nicole / Li, Mingjie / Bujarski, Sean / Hekmati, Ava / Nassir, Isabella / Hekmati, Tara / Yu, Janna / Daniely, David et al. | 2023
- 583
-
Long‐term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMaechler, Melanie / Bacher, Ulrike / Daskalakis, Michael / Nilius, Henning / Nagler, Michael / Taleghani, Behrouz Mansouri / Jeker, Barbara / Pabst, Thomas et al. | 2023
- 587
-
The impact of CD56 expression in smoldering myeloma patients on early progressionNotarfranchi, Laura / Segreto, Roberta / Vescovini, Rosanna / Dalla Palma, Anna Benedetta / Marchica, Valentina / Burroughs‐Garcia, Jessica / Toscani, Denise / Todaro, Giannalisa / Raimondi, Vincenzo / Iannozzi, Nicolas Thomas et al. | 2023
- 590
-
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105Suzuki, Tomotaka / Maruyama, Dai / Machida, Ryunosuke / Kataoka, Tomoko / Fukushima, Noriyasu / Takayama, Nobuyuki / Ohba, Rie / Omachi, Ken / Imaizumi, Yoshitaka / Tokunaga, Masahito et al. | 2023
- 594
-
Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusionsSun, Kai / Chen, Wen‐Min / Wang, Xu / Zhao, Xiao‐Su / Li, Ling‐Di / Hao, Yue / Wang, Jun / Xu, Nan / Jiang, Qian / Jiang, Hao et al. | 2023
- 598
-
Distinguishing myelodysplastic syndromes with moderate‐to‐severe bone marrow fibrosis from triple‐negative primary myelofibrosis based on clinical and genetic covariatesWu, Junying / Zhang, Wenjun / Zhang, Peihong / Qin, Tiejun / Xu, Zefeng / Sun, Qi / Jia, Yujiao / Qu, Shiqiang / Li, Bing / Wang, Huijun et al. | 2023